{
  "trial_id": "NCT03321981",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, ECOG performance status, HER2 status, hormone receptor status, prior lines of therapy, type of prior therapies (HER2-directed, endocrine, chemotherapy), measurable disease status, presence of bone-only disease, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), hemoglobin level, platelet count, serum calcium level, alanine aminotransferase (ALT) level, aspartate aminotransferase (AST) level, total bilirubin level, serum creatinine level, serum albumin level, life expectancy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "HER2 status",
        "hormone receptor status",
        "prior lines of therapy",
        "type of prior therapies (HER2-directed, endocrine, chemotherapy)",
        "measurable disease status",
        "presence of bone-only disease",
        "left ventricular ejection fraction (LVEF)",
        "absolute neutrophil count (ANC)",
        "hemoglobin level",
        "platelet count",
        "serum calcium level",
        "alanine aminotransferase (ALT) level",
        "aspartate aminotransferase (AST) level",
        "total bilirubin level",
        "serum creatinine level",
        "serum albumin level",
        "life expectancy"
      ]
    },
    "processed-gen-response": "Age, gender, ECOG performance status, HER2 status, hormone receptor status, prior lines of therapy, type of prior therapies (HER2-directed, endocrine, chemotherapy), measurable disease status, presence of bone-only disease, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), hemoglobin level, platelet count, serum calcium level, alanine aminotransferase (ALT) level, aspartate aminotransferase (AST) level, total bilirubin level, serum creatinine level, serum albumin level, life expectancy."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, HER2 Status, Hormone Receptor Status, Number of Prior Lines of Therapy, Prior Trastuzumab Treatment, Prior Pertuzumab Treatment, Prior T-DM1 Treatment, Left Ventricular Ejection Fraction (LVEF), Absolute Neutrophil Count (ANC), Hemoglobin, Platelets, Serum Calcium, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Total Bilirubin, Serum Creatinine, Serum Albumin,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "HER2 Status",
        "Hormone Receptor Status",
        "Number of Prior Lines of Therapy",
        "Prior Trastuzumab Treatment",
        "Prior Pertuzumab Treatment",
        "Prior T-DM1 Treatment",
        "Left Ventricular Ejection Fraction (LVEF)",
        "Absolute Neutrophil Count (ANC)",
        "Hemoglobin",
        "Platelets",
        "Serum Calcium",
        "Alanine Aminotransferase (ALT)",
        "Aspartate Aminotransferase (AST)",
        "Total Bilirubin",
        "Serum Creatinine",
        "Serum Albumin"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, HER2 Status, Hormone Receptor Status, Number of Prior Lines of Therapy, Prior Trastuzumab Treatment, Prior Pertuzumab Treatment, Prior T-DM1 Treatment, Left Ventricular Ejection Fraction (LVEF), Absolute Neutrophil Count (ANC), Hemoglobin, Platelets, Serum Calcium, Alanine Aminotransferase (ALT), Aspartate Aminotransferase (AST), Total Bilirubin, Serum Creatinine, Serum Albumin"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Eastern Cooperative Oncology Group (ECOG) performance status, HER2 status, Estrogen Receptor status, Progesterone Receptor status, Number of prior lines of therapy, Prior therapy, Time from diagnosis to study entry, Time from last progression to study entry, Left ventricular ejection fraction (LVEF), Absolute neutrophil count (ANC), Hemoglobin, Platelets, Serum calcium, Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Total bilirubin, Serum creatinine, Serum albumin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Race (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "HER2 status",
        "Estrogen Receptor status",
        "Progesterone Receptor status",
        "Number of prior lines of therapy",
        "Prior therapy",
        "Time from diagnosis to study entry",
        "Time from last progression to study entry",
        "Left ventricular ejection fraction (LVEF)",
        "Absolute neutrophil count (ANC)",
        "Hemoglobin",
        "Platelets",
        "Serum calcium",
        "Alanine aminotransferase (ALT)",
        "Aspartate aminotransferase (AST)",
        "Total bilirubin",
        "Serum creatinine",
        "Serum albumin"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Eastern Cooperative Oncology Group (ECOG) performance status, HER2 status, Estrogen Receptor status, Progesterone Receptor status, Number of prior lines of therapy, Prior therapy, Time from diagnosis to study entry, Time from last progression to study entry, Left ventricular ejection fraction (LVEF), Absolute neutrophil count (ANC), Hemoglobin, Platelets, Serum calcium, Alanine aminotransferase (ALT), Aspartate aminotransferase (AST), Total bilirubin, Serum creatinine, Serum albumin."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, Eastern Cooperative Oncology Group (ECOG) performance status, life expectancy, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), hemoglobin, platelets, serum calcium, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, serum creatinine, creatinine clearance, serum albumin, hormone receptor status, Human Epidermal Growth Factor Receptor (HER)2 expression, number of prior lines of therapy, prior therapy regimens.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Eastern Cooperative Oncology Group (ECOG) performance status",
        "life expectancy",
        "left ventricular ejection fraction (LVEF)",
        "absolute neutrophil count (ANC)",
        "hemoglobin",
        "platelets",
        "serum calcium",
        "alanine aminotransferase (ALT)",
        "aspartate aminotransferase (AST)",
        "total bilirubin",
        "serum creatinine",
        "creatinine clearance",
        "serum albumin",
        "hormone receptor status",
        "Human Epidermal Growth Factor Receptor (HER)2 expression",
        "number of prior lines of therapy",
        "prior therapy regimens"
      ]
    },
    "processed-gen-response": "Age, sex, race, Eastern Cooperative Oncology Group (ECOG) performance status, life expectancy, left ventricular ejection fraction (LVEF), absolute neutrophil count (ANC), hemoglobin, platelets, serum calcium, alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin, serum creatinine, creatinine clearance, serum albumin, hormone receptor status, Human Epidermal Growth Factor Receptor (HER)2 expression, number of prior lines of therapy, prior therapy regimens."
  }
}